ACT-293987

· Actelion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-293987, covering 2022-09-19 to 2022-09-19. Get the full timeline:

Most recent: Clinical Trial Update: ACT-293987 in Pulmonary Arterial Hypertension [Phase 3]